跳至主要内容
临床试验/ISRCTN62175998
ISRCTN62175998已完成未知

Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a pilot study of the Neonatal Neuroprotection of Asphyxiated Tuscan Infants (NeoNATI) Network

A. Meyer University Children?s Hospital (Italy)0 个研究点目标入组 60 人开始时间: 2011年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

  1. 2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/22950861 2. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28274169 (added 16/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Newborns with gestational age > 36 weeks and birth weigh > 1800 g with at least 1 of the following:
  • 1.1. Apgar score < 5 at 10 minutes
  • 1.2. Persisting need for resuscitation, including endotracheal intubation or mask ventilation 10 minutes after birth
  • 1.3. Acidosis (pH <7.0, base deficit >-16 mmol/L in umbilical cord blood or arterial, venous or capillary blood) within 60 minutes from birth
  • 2. Moderate to severe encephalopathy, consisting of altered state of consciousness (irritability, lethargy, stupor, or coma) and > 1 of the following signs:
  • 2.1. Hypotonia
  • 2.2. Abnormal reflexes, including oculomotor or pupil abnormalities
  • 2.3. Absent or weak suck
  • 2.4. Clinical seizures
  • 3. Abnormal ambulatory electroencephalogram (aEEG)

排除标准

  • 1. Congenital abnormalities
  • 2. Congenital viral infections
  • 3. Evidence of encephalopathy other than HIE

研究者

发起方
A. Meyer University Children?s Hospital (Italy)

相似试验

Safety and efficacy of topiramate in neonates with... | 临床试验